Alaska Personal Injury Attorneys

Located in Anchorage

Potential Heart Risk with Parkinson's Drug Stalevo

Potential Heart Risk with Parkinson's Drug Stalevo

The Los Angeles Times (8/20, Maugh) "Booster Shots" blog reported that "the Food and Drug Administration on Friday cautioned that it is investigating the possibility that the combination Parkinson's drug Stalevo [combined carbidopa/levodopa and entacapone] may increase the risk of heart attack, stroke and death in elderly patients who are taking it." The FDA "urged patients not to stop taking the drug, but warned them to let their physicians know if" they "have risk factors for cardiovascular disease."

Categories